Regulatory aspects of teratology: role of the Food and Drug Administration.
The Food and Drug Administration is a scientific regulatory agency whose consumer protection activities cover a wide range of products including foods and additives, and pesticide residues on foods; drugs; cosmetics; medical devices; and radiation-emitting electronic products. Amongst its concerns is the possible teratogen effects of regulated products to which the pregnant woman is exposed. The policies and programs of the agency directed toward reducing such risks to the unborn are reviewed. These measures include guidelines for animal reproduction studies and for clinical trials involving women to childbearing potential; labeling of products to disclose known or possible harm to the fetus or embryo; surveillance procedures designed to detect previously unsuspected adverse effects of marketed products; research activities designed to develop better understanding of developmental toxicology and improved techniques for detecting embryocidal and embryotoxic effects; and educational efforts directed both to professionals and the public regarding hazards to the unborn of agency-regulated products.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D002110:Caffeine / Q000009:adverse effects; D002986:Clinical Trials as Topic; D000013:Congenital Abnormalities / Q000175:diagnosis; D004353:Drug Evaluation, Preclinical; D004348:Drug Labeling; D000431:Ethanol / Q000009:adverse effects; D005260:Female; D006801:Humans; D010606:Pharmacy and Therapeutics Committee; D011247:Pregnancy; D011835:Radiation Protection; D013723:Teratogens / Q000633:toxicity; D014481:United States; D014486:United States Food and Drug Administration
D013723:Teratogens; D002110:Caffeine; D000431:Ethanol